These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19891891)

  • 1. Persistent extended-spectrum beta-lactamase urinary tract infection.
    DeBusscher J; Zhang L; Buxton M; Foxman B; Barbosa-Cesnik C
    Emerg Infect Dis; 2009 Nov; 15(11):1862-4. PubMed ID: 19891891
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-acquired extended-spectrum beta-lactamase producers, United States.
    Doi Y; Adams J; O'Keefe A; Quereshi Z; Ewan L; Paterson DL
    Emerg Infect Dis; 2007 Jul; 13(7):1121-3. PubMed ID: 18214201
    [No Abstract]   [Full Text] [Related]  

  • 3. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
    J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
    [No Abstract]   [Full Text] [Related]  

  • 4. Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.
    Ozden M; Kalkan A; Demirdag K; Kilic SS; Ozdarendeli A
    Int J Antimicrob Agents; 2003 May; 21(5):492-3. PubMed ID: 12727086
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiresistant extended-spectrum β-lactamase producing Escherichia coli in human urine samples in Portugal.
    Pacheco R; Correia S; Monteiro R; Gonçalves A; Radhouani H; Ramos S; Carvalho E; Carvalho J; Igrejas G; Poeta P
    J Microbiol Immunol Infect; 2013 Oct; 46(5):399-404. PubMed ID: 22727541
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children.
    Ohnishi T; Mishima Y; Takizawa S; Tsutsumi K; Amemiya A; Akiyama N; Kanna Y; Asato S; Tomita M; Ikemiyagi M; Shikoro N; Nakazawa M; Kurihara N; Kamimaki I
    Keio J Med; 2020 Jun; 69(2):43-47. PubMed ID: 31474677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
    Horie A; Nariai A; Katou F; Abe Y; Saito Y; Koike D; Hirade T; Ito T; Wakuri M; Fukuma A
    Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malakoplakia in a patient with complicated urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lee WS; Chen WY; Ou TY; Chen FL; Lin YW
    J Microbiol Immunol Infect; 2015 Jun; 48(3):345-6. PubMed ID: 24530255
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Geerlings SE; van Donselaar-van der Pant KA; Keur I
    J Antimicrob Chemother; 2010 Sep; 65(9):2048-9. PubMed ID: 20554566
    [No Abstract]   [Full Text] [Related]  

  • 11. Spread of multiresistance and extended-spectrum beta-lactamases amongst urinary Escherichia coli in Oxford, UK.
    Wyllie DH; Baxter E; Morgan M; Bowler IC
    J Antimicrob Chemother; 2005 Nov; 56(5):986-8. PubMed ID: 16183665
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Western France.
    Larramendy S; Gaultier A; Giffon S; Thibaut S; Caillon J; Moret L; Beaudeau F
    Med Mal Infect; 2020 May; 50(3):297-300. PubMed ID: 31575447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Four infants with upper urinary tract infection due to extended-spectrum bata lactamase (ESBL)-producing Escherichia coli].
    Hibino S; Fukuchi K; Abe Y; Hoshino A; Sakurai S; Mikawa T; Fuke T; Yoshida K; Itabashi K
    Kansenshogaku Zasshi; 2011 Sep; 85(5):481-7. PubMed ID: 22117375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and characteristics of Escherichia coli clonal group A.
    Johnson JR; Murray AC; Kuskowski MA; Schubert S; Prère MF; Picard B; Colodner R; Raz R;
    Emerg Infect Dis; 2005 Jan; 11(1):141-5. PubMed ID: 15705341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of CTX-M extended spectrum beta-lactamase-producing Escherichia coli in Belgium.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; De Mendonca R; Nonhoff C; Deplano A; Byl B; Struelens MJ
    Euro Surveill; 2005 Feb; 10(2):E050224.3. PubMed ID: 16687777
    [No Abstract]   [Full Text] [Related]  

  • 16. Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study.
    Castillo-Tokumori F; Irey-Salgado C; Málaga G
    Int J Infect Dis; 2017 Feb; 55():16-19. PubMed ID: 27979787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
    Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
    Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli İsolates.
    Çetinkol Y; Sandalli C; Çalgin MK; Yildirim AA; Akyildiz E; Karaman E; Çiçek AÇ
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):131-141. PubMed ID: 28420242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France.
    Duployez C; Loïez C; Cattoen C; Wallet F; Vachée A
    Med Mal Infect; 2019 Feb; 49(1):47-53. PubMed ID: 30396720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.